Frontiers in Pharmacology | Pharmacoepidemiology

Systematic Review

Published on 23 Jan 2025

Global bibliometric analysis of traditional Chinese medicine regulating gut microbiota in the treatment of diabetes from 2004 to 2024

in Pharmacoepidemiology

Jieling Liang
Xiaojuan Lin
Xin Liao
Xi Chen
Ying Zhou
Lin Zhang
Yunyun Qin
Haoru Meng
Zhongwen Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533984

3,757 views
2 citations

Original Research

Published on 23 Jan 2025

A post-marketing pharmacovigilance study of triazole antifungals: adverse event data mining and analysis based on the FDA adverse event reporting system database

in Pharmacoepidemiology

Yalan Tian
Min Jin
Hong Ning

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1462510

3,493 views
3 citations

Original Research

Published on 10 Jan 2025

Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system

in Pharmacoepidemiology

Jinming Cao
Zhicong Chen
Yan Wang
Yunpeng Ma
Zhen Yang
Jian Cai
Zhijun Xiao
Feng Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1517546

6,443 views
5 citations

Editorial

Published on 10 Jan 2025

Editorial: Biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world

in Pharmacoepidemiology

Irma Convertino
Luciane Cruz Lopes
Nicole Pratt
Ylenia Ingrasciotta
Marco Tuccori

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1542453

2,537 views
1 citation

Original Research

Published on 09 Jan 2025

Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database

in Pharmacoepidemiology

Xi-Feng Wang
Lu-Ri Bao
Ta-La Hu
Rui-Feng Xu
Wu-Niri Gao
Jing-Yuan Wang
Jian-Rong Zhao
Zhen-Li Fu
Shu-Fang Wang
Yan Meng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1440907

6,780 views
2 citations

Original Research

Published on 08 Jan 2025

Safety of combined drug use in patients with cardiovascular and cerebrovascular diseases: an analysis based on the spontaneous reporting database of adverse drug reactions in Hubei Province

in Pharmacoepidemiology

Jia Wang
Yuhang Zhao
Zherui Chen
Rui Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1451713

2,997 views
2 citations

Original Research

Published on 07 Jan 2025

Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: insights from FAERS

in Pharmacoepidemiology

Lin Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1454418

4,005 views
2 citations

Original Research

Published on 07 Jan 2025

Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database

in Pharmacoepidemiology

Wenwen Zhang
Yizhen Yin
Dan Yang
Mengyuan Liu
Caixia Ye
Ruiling Yan
Ruiman Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1475884

7,409 views
6 citations

Original Research

Published on 06 Jan 2025

Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases

in Pharmacoepidemiology

Xianyu Dai
Kai Yu
Yu Chang
Yuchuan Hou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466875

6,432 views
3 citations

Original Research

Published on 03 Jan 2025

Inappropriate prescribing of drugs for peptic ulcer and gastro-esophageal reflux disease remains a matter of concern: Results from the LAPTOP-PPI cluster randomized trial

in Pharmacoepidemiology

Manuela Casula
Ilaria Ardoino
Laura Pierini
Lara Perrella
Stefano Scotti
Sara Mucherino
Valentina Orlando
Enrica Menditto
Carlotta Franchi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1430879

3,495 views
2 citations

Original Research

Published on 23 Dec 2024

Safety assessment of deutetrabenazine: real-world adverse event analysis from the FAERS database

in Pharmacoepidemiology

Yanping Shu
Yuanhe Wang
Jiaoying Liu
Lingyan Hu
Sichao Tong
Gang Wu
Xianlin Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498215

3,553 views
2 citations

Original Research

Published on 18 Dec 2024

Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system

in Pharmacoepidemiology

Yanjun Lu
Qian Xu
Shita Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1486422

4,373 views
6 citations

Original Research

Published on 17 Dec 2024

Anti-migraine medications safety during pregnancy in the US

in Pharmacoepidemiology

A. Bérard
S. Strom
D. Albrecht
S. Kori

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1481378

3,165 views
3 citations

Original Research

Published on 17 Dec 2024

A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System

in Pharmacoepidemiology

Dongdong Zhang
Ying Cai
Yixin Sun
Peiji Zeng
Wei Wang
Wenhui Wang
Xiaohua Jiang
Yifan Lian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1442765

3,251 views
2 citations

Original Research

Published on 16 Dec 2024

Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry

in Pharmacoepidemiology

J. Riera-Arnau
E. Ballarín
R. Llop
E. Montané
P. Hereu
G. Vancells
N. Padullés-Zamora
A. M. Barriocanal
G. Cardona-Peitx
C. Casasnovas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1420682

2,007 views

Original Research

Published on 16 Dec 2024

Cost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China

in Pharmacoepidemiology

Rongqi Li
Yuhan Zeng
Yizhang Chen
Zhongjiang Ye
Chuang Chen
Jianhui Yang
Jing Fu
Tao Zhou
Danna Jiang
Sunting Qin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1412743

2,233 views

Original Research

Published on 13 Dec 2024

Drug-induced retinal vein occlusion: a disproportionality analysis from the FDA adverse event reporting system (2004–2023)

in Pharmacoepidemiology

Xiao-Dong Chen
Kun-Hong Xiao
Chao-Bing Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1480269

5,055 views
9 citations

Original Research

Published on 11 Dec 2024

A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system

in Pharmacoepidemiology

Yu Zhang
Wei Deng
Minjian Wang
Siying Luo
Song Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438661

3,631 views
5 citations

Original Research

Published on 11 Dec 2024

Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance study

in Pharmacoepidemiology

Chengzhi Liu
Xinyu Wang
Xusheng Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1502047

4,449 views
8 citations

Original Research

Published on 11 Dec 2024

Use of fluoroquinolones and risk of rhegmatogenous retinal detachment: a retrospective cohort study using two nationwide representative claims databases

in Pharmacoepidemiology

Ting-Yu Lin
Jiun-Ling Wang
Grace Hsin-Min Wang
Yu-Yun Huang
Ming-Ching Chen
Yaa-Hui Dong
Wei-Hsuan Lo-Ciganic

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1414221

2,316 views

Original Research

Published on 05 Dec 2024

Spontaneous adverse drug reactions reported in a thirteen-year pharmacovigilance program in a tertiary university hospital

in Pharmacoepidemiology

E. Montané
Y. Sanz
S. Martin
C. Pérez-Mañá
E. Papaseit
O. Hladun
G. De la Rosa
M. Farré

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1427772

3,699 views
1 citation

Original Research

Published on 03 Dec 2024

Global research trends in therapeutic drug monitoring of antimicrobials from 2000 to 2023: a bibliometric analysis

in Pharmacoepidemiology

Hao Li
Manxue Jiang
Lingti Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1474878

14,457 views
2 citations

Original Research

Published on 02 Dec 2024

Cardiovascular toxicity risk assessment of tyrosine kinase inhibitors: a pharmacovigilance study using the VigiBase database

in Pharmacoepidemiology

Yusuke Igawa
Hirofumi Hamano
Satoru Esumi
Tatsuaki Takeda
Makoto Kajizono
Ryo Kikuoka
Ikuya Kimura
Yoshito Zamami

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1472008

4,977 views
2 citations

Original Research

Published on 29 Nov 2024

Interactions of warfarin with COVID-19 vaccine/drugs, monoclonal antibodies, and targeted anticancer agents from real-world data mining

in Pharmacoepidemiology

Yan Gao
Qingsong Huang
Jun Li
Junsheng He
Fang Qian
Juanjuan Yi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418997

3,585 views
2 citations

601 articles

articles

Global bibliometric analysis of traditional Chinese medicine regulating gut microbiota in the treatment of diabetes from 2004 to 2024

A post-marketing pharmacovigilance study of triazole antifungals: adverse event data mining and analysis based on the FDA adverse event reporting system database

Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system

Editorial: Biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world

Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database

Safety of combined drug use in patients with cardiovascular and cerebrovascular diseases: an analysis based on the spontaneous reporting database of adverse drug reactions in Hubei Province

Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: insights from FAERS

Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database

Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases

Inappropriate prescribing of drugs for peptic ulcer and gastro-esophageal reflux disease remains a matter of concern: Results from the LAPTOP-PPI cluster randomized trial

Safety assessment of deutetrabenazine: real-world adverse event analysis from the FAERS database

Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system

Anti-migraine medications safety during pregnancy in the US

A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System

Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry

Cost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China

Drug-induced retinal vein occlusion: a disproportionality analysis from the FDA adverse event reporting system (2004–2023)

A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system

Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance study

Use of fluoroquinolones and risk of rhegmatogenous retinal detachment: a retrospective cohort study using two nationwide representative claims databases

Spontaneous adverse drug reactions reported in a thirteen-year pharmacovigilance program in a tertiary university hospital

Global research trends in therapeutic drug monitoring of antimicrobials from 2000 to 2023: a bibliometric analysis

Cardiovascular toxicity risk assessment of tyrosine kinase inhibitors: a pharmacovigilance study using the VigiBase database

Interactions of warfarin with COVID-19 vaccine/drugs, monoclonal antibodies, and targeted anticancer agents from real-world data mining